Online inquiry

IVTScrip™ mRNA-Human ATAD3C, (Cap 0, 5-Methyl-CTP & Pseudo-UTP, 120 nt-poly(A))   (CAT#: GTTS-WK23340MR)

This product GTTS-WK23340MR is a type of mRNA having 120 nt poly(A) tail and modified with Cap 0 & 5-Methyl-CTP & Pseudo-UTP. It ecodes the ATAD3C protein. This product can be used in SLC16A7+ cell-related researches.
Specifications
Product type mRNA
Modified bases 5-Methyl-CTP & Pseudo-UTP
5' Cap Cap 0
Species Human
RefSeq NM_001039211.3
Applications Gene therapy research
Format Powder
Quantity 100 µg
Purification Chromatography
Target Gene
Gene ID 219293
UniProt ID Q5T2N8
Download
Download resources about mRNA therapeutics development to boost your research.
CUSTOMER REVIEWS and Q&As

There are currently no Customer reviews or questions for IVTScrip™ mRNA-Human ATAD3C, (Cap 0, 5-Methyl-CTP & Pseudo-UTP, 120 nt-poly(A)) (GTTS-WK23340MR). Click the button above to contact us or submit your feedback about this product.

See other products
CAT Product Name Product Type CDs
GTTS-WK2101MR IVTScrip™ mRNA-Human Intestinal Alkaline Phosphatase, (Cap 0, N1-Methylpseudo-UTP, 30 nt-poly(A)) mRNA Intestinal Alkaline Phosphatase
GTTS-WK19600MR IVTScrip™ mRNA-Human ALDH3A2, (Cap 1, 5-Methyl-CTP & Pseudo-UTP, 120 nt-poly(A)) mRNA ALDH3A2
GTTS-WK26885MR IVTScrip™ mRNA-Human ARSI, (Cap 1, 5-Methyl-CTP & Pseudo-UTP, 120 nt-poly(A)) mRNA ARSI
GTTS-WK11835MR IVTScrip™ mRNA-Human ACOT4, (Cap 1, 2-Thio-UTP, 120 nt-poly(A)) mRNA ACOT4
GTTS-WK20748MR IVTScrip™ mRNA-Human AK3, (Cap 1, 2-Thio-UTP, 30 nt-poly(A)) mRNA AK3
GTTS-WK11313MR IVTScrip™ mRNA-Human ADARB1, (Cap 1, N1-Methylpseudo-UTP, 120 nt-poly(A)) mRNA ADARB1
GTTS-WK5274MR IVTScrip™ mRNA-Human AMACR, (Cap 1, 5-Methyl-CTP & Pseudo-UTP, 120 nt-poly(A)) mRNA AMACR
GTTS-WK28197MR IVTScrip™ mRNA-Human ATP5D, (Cap 1, 2-Thio-UTP, 30 nt-poly(A)) mRNA ATP5D
All products and services are For Research Use Only and CANNOT be used in the treatment or diagnosis of disease.
webinar

EABR Nanoparticles as a Platform Technology for Hybrid mRNA Vaccine Development

November 20th, 2024, 2 PM–3 PM EST

REGISTER NOW